SE9404568L - Användning av inositoltrisfosfat för beredning av läkemedel - Google Patents

Användning av inositoltrisfosfat för beredning av läkemedel

Info

Publication number
SE9404568L
SE9404568L SE9404568A SE9404568A SE9404568L SE 9404568 L SE9404568 L SE 9404568L SE 9404568 A SE9404568 A SE 9404568A SE 9404568 A SE9404568 A SE 9404568A SE 9404568 L SE9404568 L SE 9404568L
Authority
SE
Sweden
Prior art keywords
drug preparation
inositol trisphosphate
trisphosphate
inositol
drug
Prior art date
Application number
SE9404568A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9404568D0 (sv
Inventor
Matti Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE9404568A priority Critical patent/SE9404568L/
Publication of SE9404568D0 publication Critical patent/SE9404568D0/xx
Priority to PCT/SE1995/001585 priority patent/WO1996020715A1/en
Priority to AT95942373T priority patent/ATE247474T1/de
Priority to AU43619/96A priority patent/AU4361996A/en
Priority to DE69531554T priority patent/DE69531554T2/de
Priority to EP95942373A priority patent/EP0794786B1/de
Priority to JP8520899A priority patent/JPH10511677A/ja
Publication of SE9404568L publication Critical patent/SE9404568L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9404568A 1994-12-30 1994-12-30 Användning av inositoltrisfosfat för beredning av läkemedel SE9404568L (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9404568A SE9404568L (sv) 1994-12-30 1994-12-30 Användning av inositoltrisfosfat för beredning av läkemedel
PCT/SE1995/001585 WO1996020715A1 (en) 1994-12-30 1995-12-22 The use of inositoltrisphosphate for the preparing of medicaments
AT95942373T ATE247474T1 (de) 1994-12-30 1995-12-22 Verwendung von inosittriphosphat zur herstellung von arzneimitteln
AU43619/96A AU4361996A (en) 1994-12-30 1995-12-22 The use of inositoltrisphosphate for the preparing of medicaments
DE69531554T DE69531554T2 (de) 1994-12-30 1995-12-22 Verwendung von inosittriphosphat zur herstellung von arzneimitteln
EP95942373A EP0794786B1 (de) 1994-12-30 1995-12-22 Verwendung von inosittriphosphat zur herstellung von arzneimitteln
JP8520899A JPH10511677A (ja) 1994-12-30 1995-12-22 イノシトール三燐酸の薬剤調製への使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9404568A SE9404568L (sv) 1994-12-30 1994-12-30 Användning av inositoltrisfosfat för beredning av läkemedel

Publications (2)

Publication Number Publication Date
SE9404568D0 SE9404568D0 (sv) 1994-12-30
SE9404568L true SE9404568L (sv) 1996-07-01

Family

ID=20396521

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9404568A SE9404568L (sv) 1994-12-30 1994-12-30 Användning av inositoltrisfosfat för beredning av läkemedel

Country Status (7)

Country Link
EP (1) EP0794786B1 (de)
JP (1) JPH10511677A (de)
AT (1) ATE247474T1 (de)
AU (1) AU4361996A (de)
DE (1) DE69531554T2 (de)
SE (1) SE9404568L (de)
WO (1) WO1996020715A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005361A (es) * 2001-12-13 2004-09-27 Vital Health Sciences Pyt Ltd Transporte transdermico de compuestos.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
SG184181A1 (en) 2010-03-30 2012-10-30 Phosphagenics Ltd Transdermal delivery patch
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
EP3383371B1 (de) 2015-12-09 2024-05-01 Avecho Biotechnology Limited Pharmazeutische formulierung
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
US4952396A (en) * 1986-11-19 1990-08-28 Linus Pauling Institute Of Science & Medicine Method of using phytic acid for inhibiting tumor growth

Also Published As

Publication number Publication date
JPH10511677A (ja) 1998-11-10
WO1996020715A1 (en) 1996-07-11
DE69531554D1 (de) 2003-09-25
ATE247474T1 (de) 2003-09-15
AU4361996A (en) 1996-07-24
EP0794786B1 (de) 2003-08-20
EP0794786A1 (de) 1997-09-17
SE9404568D0 (sv) 1994-12-30
DE69531554T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
UA32525C2 (uk) Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення
FI964332A0 (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
LV11985A (lv) Noteiktu cistina atvasinajumu farmakologiska izmantosana
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
SE9404568L (sv) Användning av inositoltrisfosfat för beredning av läkemedel
DK376188A (da) Farmaceutisk dosisenhed
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
SE9002342D0 (sv) Medicament
SE9303289L (sv) Användning av inositoltrisfosfat för beredning av läkemedel
IL89325A0 (en) Optically active rhodium complexes of 3,4-bis(diarylphosphino)pyrrolidines and their use for the preparation of phosphinothricin by asymmetric hydrogenation
SE9504594L (sv) Användning av en ester av inositoltrisfosfat för beredning av läkemedel
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
SE9303855L (sv) Användning av en inositoltrisfosfatester för beredning av ett smärtstillande läkemedel
SE9203296L (sv) Användning av inositolreisfosfat för beredning av läkemedel
IL97509A0 (en) Lipid lowering compositions comprising bambuterol
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
FR2390421A1 (fr) 1-acyl-2-hydroxy-1,3-diaminopropanes a titre de nouveaux medicaments
CA2033975A1 (en) Use of .beta.-receptor blocking agents
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9404568-9

Format of ref document f/p: F